Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?

Farhad Ravandi; Hagop Kantarjian

doi:10.1016/S1470-2045(15)00210-7

Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?

Farhad Ravandi, Hagop Kantarjian

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1274-1275
Number of pages	2
Journal	The lancet oncology
Volume	16
Issue number	13
DOIs	https://doi.org/10.1016/S1470-2045(15)00210-7
State	Published - 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(15)00210-7

Cite this

@article{647af9d407a0412c9c207121d98786ba,

title = "Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?",

author = "Farhad Ravandi and Hagop Kantarjian",

note = "Funding Information: FR and HK have been members of advisory boards and have received research funding from Pfizer.",

year = "2015",

doi = "10.1016/S1470-2045(15)00210-7",

language = "English (US)",

volume = "16",

pages = "1274--1275",

journal = "The lancet oncology",

issn = "1470-2045",